Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-13FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental NDA for Depakote Sprinkles (divalproex sodium) from AbbVie, updating labeling and/or indications for the Spr…
-
FDA approval · 2015-03-10FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Keppra (levetiracetam) filed by UCB, Inc., updating the labeling.
-
FDA approval · 2015-03-10FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for KEPPRA (levetiracetam) from UCB, Inc.
-
FDA approval · 2015-03-10FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for KEPPRA XR (levetiracetam) from UCB, authorizing an extended-release formulation for use in epile…
-
FDA approval · 2015-03-10FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Keppra (levetiracetam) submitted by UCB, Inc., reflecting an update to the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-03-09FDA Approved: DIAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a Teva supplemental application for Diazepam, resulting in an approved labeling change under ANDA 071321.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]
This Clinical Trial Update reports the completion of a Phase 3 study evaluating long-term safety and efficacy of pregabalin in patients with…
-
FDA approval · 2015-03-05FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Gabapentin from Aurobindo Pharma Limited, enabling the generic product's continued marketing und…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures [Phase 2]
A Phase 2 cognition study of levetiracetam in children with partial-onset seizures has completed (19-week evaluation).
-
FDA approval · 2015-02-25FDA Approved: LEVETIRACETAM — Original Application (Apotex Corp.)
FDA approves Apotex Corp's generic levetiracetam for the treatment of seizures associated with epilepsy under an Original Application. This …
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Prospective Study of Comparison Between the Modified Atkins Diet and Classic Ketogenic Diet for Intractable Childhood Epilepsy
A prospective study comparing the Modified Atkins Diet and the Classic Ketogenic Diet for intractable childhood epilepsy has completed. The …
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures [Phase 3]
An open-label extension trial evaluated the safety of USL255 in patients with refractory partial-onset seizures as part of a Phase 3 program…
-
FDA approval · 2015-02-18FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for carbamazepine filed by Apotex Corp., indicating an approved modification to the generic prod…
-
FDA approval · 2015-02-18FDA Approved: LEVETIRACETAM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for LEVETIRACETAM from Bionpharma Inc., resulting in updated labeling for the product.
-
FDA approval · 2015-02-18FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for lamotrigine by Advagen Pharma Limited (ANDA 078625).
-
CLINICAL_TRIALS research · 2015-02-13Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy [NA]
This entry reports an update on a clinical trial evaluating transcutaneous auricular vagus nerve stimulation for pediatric epilepsy, sponsor…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures [Phase 3]
Phase 3 trial evaluating adjunctive lacosamide in adults with partial-onset seizures has completed and results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-02-06Clinical Trial Update: Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies [NA]
A clinical trial evaluating episodic memory before and after surgical treatment in patients with drug-resistant partial epilepsy. The study …
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Enhancing Antiepileptic Drug Adherence [NA]
A completed clinical trial conducted by Qazvin University of Medical Sciences evaluating strategies to improve adherence to antiepileptic dr…
-
FDA approval · 2015-02-04FDA Approved: OXCARBAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application for Oxcarbazepine. This action updates the drug's labeling.
-
FDA approval · 2015-02-04FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for oxcarbazepine submitted by Amneal Pharmaceuticals LLC, expanding the regulatory authorizatio…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Pharmacodynamics of Nasal and Buccal Midazolam Using EEG [Phase 1]
A Phase 1 study evaluated the pharmacodynamics of nasal and buccal midazolam using EEG in epilepsy. The study status is TERMINATED.
-
FDA approval · 2015-02-03FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for KLONOPIN (clonazepam) filed by H2-Pharma, LLC.
-
FDA approval · 2015-02-03FDA Approved: LEVETIRACETAM — Supplemental Application (WG Critical Care, LLC)
The FDA approved a supplemental application for levetiracetam from WG Critical Care, LLC, indicating a labeling/indication change for the dr…
-
CLINICAL_TRIALS research · 2015-01-29Clinical Trial Update: An Exploratory RCT of a Psychosocial Group Intervention for Epilepsy [NA]
This item describes an exploratory randomized controlled trial evaluating a psychosocial group intervention for epilepsy, with no results or…